The Trump administration has issued numerous pharma-focused executive orders, including “Lowering Drug Prices by Once Again Putting Americans ...

The researchers interpret their findings as supporting existing cautionary guidance from the European Medicines Agency (EMA) ...

The Ixchiq vaccine was approved for adults 18 and up at risk of exposure to the virus in 2023, when the CDC had recorded 152 ...

NRX.V READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) (TSX:NRX.V) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also ...

Heart failure occurs when the heart is unable to pump enough blood to meet the body’s needs. While it can affect people at ...

Nvidia and AMD have reportedly agreed to pay the US 15% of the revenue for AI-related chip sales to China, adding a ...

D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedulePresented positive 60-week res ...

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...

Pegozafermin, ETNB's FGF21 analog, shows promise in late-stage trials for MASH & severe hypertriglyceridemia. Key data & ...

Houston Center Cleared to Commence Commercial Sales of Normal Source PlasmaState of the Art Facility has Annual Collection Capacity of Approximately 50,000 Liters of Plasma and an Estimated Annual Rev ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Committee for Orphan Medicinal Products (COMP) of the ...